1.1250
+0.0250
+(2.27%)
As of January 30 at 3:42:08 PM GMT. Market Open.
Breakdown
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Assets
422.6030
674.3930
1,115.4160
1,323.2840
Total Liabilities Net Minority Interest
140.0760
142.6730
140.6090
157.5700
Total Equity Gross Minority Interest
282.5270
531.7200
974.8070
1,165.7140
Total Capitalization
282.5270
531.7200
974.8070
1,165.7140
Common Stock Equity
282.5270
531.7200
974.8070
1,165.7140
Net Tangible Assets
278.1480
526.2410
971.8020
1,162.2790
Working Capital
261.3190
518.3040
957.0420
1,146.5790
Invested Capital
282.5270
531.7200
974.8070
1,165.7140
Tangible Book Value
278.1480
526.2410
971.8020
1,162.2790
Share Issued
135,472.4780
97,424.7780
97,424.7780
97,334.7780
Ordinary Shares Number
135,472.4780
97,424.7780
97,424.7780
97,334.7780
6/30/2021 - 12/20/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARDX.MX Ardelyx, Inc.
105.50
0.00%
SAR.L Sareum Holdings plc
20.20
-1.46%
CIZ.L Cizzle Biotechnology Holdings Plc
1.7000
-2.86%
FAB.L Fusion Antibodies plc
8.73
+7.78%
SYRE Spyre Therapeutics, Inc.
22.27
+1.69%
SNG.L Synairgen plc
2.7000
+17.14%
HVO.L hVIVO plc
19.00
0.00%
PASG Passage Bio, Inc.
0.5848
+1.46%
IMM.L ImmuPharma plc
6.15
+13.89%
GUTS Fractyl Health, Inc.
1.9400
-3.96%